Ipsen S.A. (I7G.F)
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.
160.80-0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+55.5%
The outlook
Ipsen S.A. currently reads as bullish based on above its 50- & 200-day averages, 83% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range83% of the way from its 52-week low to high
Market cap
$13.29B
52-wk high
172.70
52-wk low
102.80
50-day avg
159.94
200-day avg
146.35
Trailing P/E
30.3